Chinese Academy of Medical Sciences COVID-19 vaccine

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Chinese Academy of Medical Sciences COVID-19 vaccine
Vaccine description
TargetSARS-CoV-2
Vaccine typeInactivated
Clinical data
Routes of
administration
Intramuscular
Legal status
Legal status
  • Emergency authorization: China [1]
Identifiers
DrugBank

Chinese Academy of Medical Sciences COVID-19 vaccine is a COVID-19 vaccine developed by Chinese Academy of Medical Sciences.[2][3]

Authorizations[edit]

  Full authorization
  Emergency authorization

On 9 June 2021, The vaccine has been approved by the Chinese authorities.[1]

References[edit]

  1. ^ a b Liu R, Woo R (9 June 2021). "China builds new plant for IMBCAMS COVID-19 vaccine -state media". Reuters. Retrieved 15 June 2021.
  2. ^ Clinical trial number NCT04412538 for "Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19" at ClinicalTrials.gov
  3. ^ Clinical trial number NCT04659239 for "The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19" at ClinicalTrials.gov

External links[edit]